By Jeff Overley ( October 23, 2017, 10:00 PM EDT) -- A Native American tribe that acquired patents for Allergan's blockbuster eye drug Restasis is sharply criticizing generic-drug makers for questioning its sovereign immunity from Patent Trial and Appeal Board proceedings, saying the attacks lack "any coherent legal theory."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.